Abstract

Purpose : To evaluate the possible role of essential fatty acids, specifically gamma-linolenic and eicosapentaenoic acid, in the amelioration of early and late radiation damage to the skin. Methods and Materials : Skin sites on the flank of 22–25 kg female large white pigs were irradiated with either single or fractionated doses (20 F/28 days) of ,β-rays from 22.5 mm diameter 90Sr 90Y plaques at a dose rate of ∼3 Gy/min. Essential fatty acids were administered orally in the form of two ‘active’ oils, So-1100 and So-5407, which contained gamma-linolenic acid and a mixture of that oil with eicosapentaenoic acid, respectively. Oils (1.5–6.0 ml) were given daily for 4 weeks prior, both 4 weeks prior and 10–16 weeks after, or in the case of one single dose study, just for 10 weeks after irradiation. Control animals received a ‘placebo’ oil, So-1129, containing no gamma linolenic acid or eicosapentaenoic acid over similar time scales before and after irradiation. Acute and late skin reactions were assessed visually and the dose-related incidence of a specific reaction used to compare the effects of different treatment schedules. Results : A redaction in the severity of both the early and late radiation reactions in the skin was only observed when ‘active’ oils were given over the time course of the expression of radiation damage. Prior treatment with oils did not modify the radiation reaction. A 3.0 ml daily dose of either So-1100 or So-5407 given prior to, but also after irradiation with single and fractionated doses of β-rays produced the most significant modification to the radiation reactions, effects consistent with dose modification factors between 1.06 – 1.24 for the acute reactions of bright red erythema and/or moist desquamation, and of 1.14-1.35 for the late reactions of dusky/mauve erythema and dermal necrosis. There was the strong suggestion of an effect produced by the `placebo' oil, So-1129, after higher daily doses of oil. Conclusions : Essential fatty acids can modulate normal tissue reactions when given over the time when radiation damage is normally expressed. Dose modification factors suggest that a ≥ 10% higher dose is required to produce the same level of normal tissue injury. Clinical application of selected essential fatty acids at appropriate doses may lead to a significant increase in the therapeutic gain in patients treated for cancer by radiotherapy.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call